Fixing the injustice of high drug prices: The Tipline for 31 January 2018

31 January 2018

This morning’s keenly anticipated state of antitrust news covers pharma litigation in the First Circuit and a bid for class certification in Northern California, plus a preview of a GCR Live Miami panel on efficiencies.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Tipline

End of the FTC as we know it: The Tipline for 27 January 2023
The Federal Trade Commission may cease to exist as it does today if it continues down its current path, Christine Wilson has said. The FTC’s sole Republican commissioner told a largely chummy audience at George Mason University yesterday that there are some “shocking things” going on behind the scenes at the agency, suggesting that the Bureau of Competition may inevitably find its powers consolidated down the block at Main Justice. Also in Tipline, Dechert …
Bridging troubled waters: The Tipline for 26 January 2023
Don’t blame me: The Tipline for 25 January 2023